Latest News

Long-Term Extension Highlights Sustained Therapeutic Benefits of Fenfluramine
Long-Term Extension Highlights Sustained Therapeutic Benefits of Fenfluramine

May 9th 2025

Over long-term treatment, fenfluramine significantly reduced seizure frequency, increased seizure-free days, and improved quality of life in patients with Dravet syndrome.

Muscle MRI May Serve as Sensitive Biomarker for ALS Disease Progression
Muscle MRI May Serve as Sensitive Biomarker for ALS Disease Progression

May 8th 2025

Evan L. Smith, PhD  (Credit: University of Michigan)
Psychological Perspective on the Role of Mental Health in MS Rehabilitation and Care

May 8th 2025

Antidopaminergic Medications Worsen Outcomes in Huntington Disease, Study Shows
Antidopaminergic Medications Worsen Outcomes in Huntington Disease, Study Shows

May 8th 2025

Parkinson Cell Therapy ANPD001 Generates Promising Early-Stage Phase 1/2 Data
Parkinson Cell Therapy ANPD001 Generates Promising Early-Stage Phase 1/2 Data

May 7th 2025

Coverage of the 2025 AAN Annual Meeting

Get direct access to interviews with experts, as well as the latest data and clinical news updates, straight from the conference floor in San Diego.

AAN 2025

Conference Coverage

View All
Roy H. Hamilton, MD, MS, FAAN
Enhancing Brain Plasticity by Personalized and Closed-Loop Neuromodulation: Roy H. Hamilton, MD, MS, FAAN

May 8th 2025

 Chitra Venkatasubramanian, MBBS, MD, MSc, FNCS
Evolving Evidence and Clinical Confidence for Blood Pressure Management in Intracerebral Hemorrhage: Chitra Venkatasubramanian, MBBS, MD, MSc, FNCS

May 8th 2025

MDA Ambassador Sunny Brous: Progress, Advocacy, and Connection in ALS
MDA Ambassador Sunny Brous: Progress, Advocacy, and Connection in ALS

May 6th 2025

Jack P. Antel, MD (Credit:ACTRIMS)
Evolving Clinical Insights Into Neuroimmune Mechanisms and Multiple Sclerosis Progression

May 2nd 2025

Video Series
Video Interviews
Podcasts

Most Recent

© 2025 MJH Life Sciences

All rights reserved.